aod9604 half life pharmacokinetics AOD-9604 💉 Peptide Timing Matters: Why

Research examines how NNMT inhibition increases NAD+ levels, activates sirtuin longevity pathways, and shifts cellular metabolism from energy storage toward energy expenditure

While more human research is needed, current user feedback and practitioner insights suggest the following best practices: Standard Dosage Most users take 50100 mg per day , typically in divided doses (e.g., 2550 mg twice daily) to maintain stable blood levels

Quality-control risk Because there is no FDA-approved AOD-9604 product, all material in circulation comes from research-supply or compounding sources

Week 1-2: 50 mg daily to assess GI tolerance, energy changes, and side effects

An under-dosed product will never achieve the target plasma concentration, making any half-life calculation irrelevant